VivoSeq
Immunology

Allergic Rhinitis

195

Pipeline Programs↗

31

Active Trials↗

61

Companies Involved↗

Allergic Rhinitis is a highly competitive landscape with 195 programs across 61 companies. The most active players are Gilead, BioTech Tools S.A., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. 37 therapies are approved with 55 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

80/100

Pipeline Velocity

27/100

Mech. Concentration

41/100

Completion Rate

92/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Gilead logo

Gilead

3 programs

Phase 1B

BioTech Tools S.A.

1 program

Phase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd. logo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

1 program

Phase 1Roche logo

Roche

4 programs

Phase 1Johnson & Johnson Pharmaceutical Research & Development, L.L.C. logo

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

2 programs

Phase 2N

Nasus Pharma

2 programs

Phase 2

Pipeline

Programs by Phase

Preclinical33

Montelukast Sodium

AstraZeneca

Beclomethasone

Chiesi Farmaceutici S.p.A.

Bilastine

Menarini International Operations Luxembourg SA

Dexamethasone Sodium Phosphate

Quince Therapeutics S.p.A.

Omalizumab

Roche

Phase 123

Idelalisib

Gilead

Ketorolac Tromethamine

Roche

Esketamine

Wim Janssens

Gpasit+tm

BioTech Tools S.A.

AZD8848

AstraZeneca

Phase 247

GSK256066

GSK

Dupilumab

Azienda U.S.L. 1 di Massa e Carrara

Tezepelumab

AstraZeneca

AD17002

Advagene Biopharma Co. Ltd.

Nacl

Bayer

Phase 355

Pseudoephedrine

Kenvue Brands

Triamcinolone

Bassett Healthcare

Prednisone

Roxane Laboratories

Fluticasone

Paratek Pharmaceuticals Inc

Active Comparator

Moderna

Approved37

Ibuprofen

Kenvue Brands

Desloratadine

Organon and Co

Ciclesonide

Azurity Pharmaceuticals

Loratadine

Perrigo Company

Beclomethasone Dipropionate

Schering-Plough

Analysis

Modality Breakdown

97%

Small molecule

233 of 239 classified programs — the dominant modality here.

3%ALL OTHERSMonoclonal antibody31%Protein / enzyme2<1%Cell therapy1<1%

Small molecule leads; the ring shows all 239 classified programs, each share of the total. Modality classified for 100% of 272 pipeline programs.

Analysis

Trial Status

316

clinical trials

Completed240 · 76%
Unknown status24 · 8%
Terminated13 · 4%
Not yet recruiting12 · 4%
Recruiting10 · 3%
Withdrawn8 · 3%
Other9 · 3%

Clinical Trials

Trial Activity

316 trials

The Treatment of Moderate to Severe Allergic Rhinitis With Electroacupuncture Combined With Microneedle Knife
Recruiting·—·N/A·NCT06890260·90 enrolled
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
Recruiting·ZZheng Liu ENT·Phase 4·NCT05080322·150 enrolled
Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
Recruiting·Daewon Pharmaceutical Co., Ltd. logoDaewon Pharmaceutical Co., Ltd.·Phase 3·NCT07168473·274 enrolled
Study of Stapokibart Injection in Patients With Allergic Rhinitis
Recruiting·KKeymed Biosciences Co.Ltd·Phase 2·NCT06525597·120 enrolled
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Recruiting·Eli Lilly logoEli Lilly·Phase 3·NCT06339008·450 enrolled
Study on the Effect and Mechanism of Lupatadine Fumarate in the Treatment of Allergic Rhinitis
Recruiting·—·N/A·NCT06709092·60 enrolled
Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites
Recruiting·TThe First Affiliated Hospital with Nanjing Medical University·N/A·NCT06427577·40 enrolled
Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis
Recruiting·—·N/A·NCT06462417·15 enrolled
Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis
Recruiting·TTanta University·N/A·NCT07115342·120 enrolled
Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice
Recruiting·KKarolinska Institutet·Approved·NCT07651891·40 enrolled
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
Active, not recruiting·HHAL Allergy·Phase 3·NCT06920771·552 enrolled
Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.
Active, not recruiting·QQueen's University·N/A·NCT06828484·20 enrolled
Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis
Active, not recruiting·YYingu Pharmaceutical Co., Ltd·Phase 4·NCT05038202·450 enrolled
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
Active, not recruiting·HHouse Ear Institute·Phase 4·NCT04815187·39 enrolled
Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)
Active, not recruiting·—·Phase 2·NCT06189742·19 enrolled
Page 1 of 22

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)